Hans Hull, Chief Business Officer: Pliant Therapeutics PLRX Sell · Filed 23/04/03

Trade details

Type: Insider sale
Amount: $239,634.72
Shares · price: 9,036 sh · $26.52 a share
Held after: 201,964 sh
Stock: Pliant Therapeutics PLRX
Person: Hans HullChief Business Officer
Trade date: 23/03/30
Filed: 23/04/03
Days to filing: 4 days

Sold 4.3% of holdings

Share of holding sold: 4.3%

Pliant Therapeutics trades, last 26 weeks

What else happened in Pliant Therapeutics around then

Filed or reported within 30 days of the trade day · 23/02/28~23/04/29

Hans Hull's recent trades

Hans HullChief Business Officer
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$178.5K
15,936 sh
$178.5K
Filed 25/01/22
Traded 25/01/17
Hans HullChief Business Officer
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$114.4K
9,900 sh
$114.4K
Filed 24/07/12
Traded 24/07/10
Hans HullChief Business Officer
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$168.6K
9,786 sh
$168.6K
Filed 24/01/19
Traded 24/01/17
Hans HullChief Business Officer
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$401.2K
20,050 sh
$401.2K
Filed 23/08/07
Traded 23/08/04
Hans HullChief Business Officer
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$261.4K
13,069 sh
$261.4K
Filed 23/08/07
Traded 23/08/03